Cohance Lifesciences Peer Comparison

NSE: COHANCE | BSE: 543064

₹459.45

up-down-arrow ₹3.05 (0.67%)

As on 19-Nov-2026IST

Market cap

info icon

₹17,567 Cr

Revenue (TTM)

info icon

₹2,063 Cr

P/E Ratio

info icon

370.8

P/B Ratio

info icon

4.5

Div. Yield

info icon

0 %

Edit peer-selector-edit
Cohance Lifesciences Acutaas Chemicals Wockhardt Piramal Pharma Rubicon Research
Market cap (₹ Cr)
17,567 32,591 35,535 31,872 28,572
Revenue (₹ Cr)
2,063 1,593 3,751 9,779 2,100
Net Profit (₹ Cr)
-5.59 438.64 405.00 -270.51 324.79
Net Margin (%)
-0.27 27.16 10.48 -2.71 15.36
RoE (%)
1.74 25.02 7.91 -2.55 24.02
Price to Earnings
370.85 74.21 86.67 -- 87.96
Price-To-Book
4.49 17.55 6.89 3.91 20.17

Income Statement (₹ Cr)

Liabilities (₹ Cr)

Assets (₹ Cr)

Cashflow (₹ Cr)

Ratios

Profitability Ratios

Growth Ratios

Valuation Ratios

Solvency Ratios

Operating Efficiency Ratios

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month